Novavax, Inc. (NVAX) Baird 2024 Global Healthcare Conference (Transcript) Novavax in $123.8M settlement with U.K. agency over COVID vaccine deal Novavax stock plunges as FDA puts clinical hold on ...

With its significant cash infusions from offloading its COVID assets, Novavax had just over $1 billion as it exited Q3, 2024.

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...